Extended Data Fig. 2: Comparison of post-transplant longitudinal eGFR values (mean of the records of each month) of AA kidney transplant patients (ICD Z94.0 or V42.0) carrying the LILRB3-4SNPs variant (‘Risk’) vs reference (‘Non-risk’, blue) allele in the BioMe cohort. | Nature Medicine

Extended Data Fig. 2: Comparison of post-transplant longitudinal eGFR values (mean of the records of each month) of AA kidney transplant patients (ICD Z94.0 or V42.0) carrying the LILRB3-4SNPs variant (‘Risk’) vs reference (‘Non-risk’, blue) allele in the BioMe cohort.

From: LILRB3 genetic variation is associated with kidney transplant failure in African American recipients

Extended Data Fig. 2

a) longitudinal eGFR values of risk and non-risk AA kidney transplant patients within 48 months after transplant. Bold curves indicate the fitted regression lines for two groups. Comparison (Students’ T test, two-sided) of average eGFR between risk (n=9) and non-risk (n=90) patients within 3 months (b), 3–24 months (c), and 3–48 months (d) after transplant. Each dot represents a sample and the box and whiskers plots showing the distribution (thick bar, median; box, 25th to 75th percentile, whiskers reach to the largest/smallest observations within 1.5 box-heights of the box).

Back to article page